-
1
-
-
27144501683
-
Biologic therapy for psoriasis: An update on the tumor necrosis factor inhibitors infliximab, etanercept, and adalimumab, and the T-cell-targeted therapies efalizumab and alefacept
-
Weinberg JM, Bottino CJ, Lindholm J, et al. Biologic therapy for psoriasis: an update on the tumor necrosis factor inhibitors infliximab, etanercept, and adalimumab, and the T-cell-targeted therapies efalizumab and alefacept. J Drugs Dermatol. 2005;4:544-555.
-
(2005)
J Drugs Dermatol
, vol.4
, pp. 544-555
-
-
Weinberg, J.M.1
Bottino, C.J.2
Lindholm, J.3
-
3
-
-
6444222553
-
Etanercept in psoriasis
-
Papp KA. Etanercept in psoriasis. Expert Opin Pharmacother. 2004;5:2139-2146.
-
(2004)
Expert Opin Pharmacother
, vol.5
, pp. 2139-2146
-
-
Papp, K.A.1
-
4
-
-
35348821885
-
-
Enbrel [package insert, Thousand Oaks, Calif: Immunex Corporation; 2006
-
Enbrel [package insert]. Thousand Oaks, Calif: Immunex Corporation; 2006.
-
-
-
-
5
-
-
85047690924
-
Bullous pemphigoid. occurrence in psoriasis treated with psoralens plus long-wave ultraviolet radiation
-
Abel EA, Bennett A. Bullous pemphigoid. occurrence in psoriasis treated with psoralens plus long-wave ultraviolet radiation. Arch Dermatol. 1979;115:988-989.
-
(1979)
Arch Dermatol
, vol.115
, pp. 988-989
-
-
Abel, E.A.1
Bennett, A.2
-
6
-
-
0020445039
-
Delayed onset of bullous pemphigoid after PUVA and sunlight treatment of psoriasis
-
Albergo RP, Gilgor RS. Delayed onset of bullous pemphigoid after PUVA and sunlight treatment of psoriasis. Cutis. 1982;30:621-624.
-
(1982)
Cutis
, vol.30
, pp. 621-624
-
-
Albergo, R.P.1
Gilgor, R.S.2
-
7
-
-
0029555746
-
Bullous pemphigoid possibly induced by psoralen plus ultraviolet A therapy
-
George PM. Bullous pemphigoid possibly induced by psoralen plus ultraviolet A therapy. Photodermatol Photoimmunol Photomed. 1996;11:185-187.
-
(1996)
Photodermatol Photoimmunol Photomed
, vol.11
, pp. 185-187
-
-
George, P.M.1
-
8
-
-
0029803868
-
Bullous pemphigoid induced by PUVA therapy
-
Perl S, Rappersberger K, Fodinger D, et al. Bullous pemphigoid induced by PUVA therapy. Dermatology. 1996;193:245-247.
-
(1996)
Dermatology
, vol.193
, pp. 245-247
-
-
Perl, S.1
Rappersberger, K.2
Fodinger, D.3
-
9
-
-
21644481166
-
A global phase III randomized controlled trial of etanercept in psoriasis: Safety, efficacy, and effect of dose reduction
-
Papp KA, Tyring S, Lahfa M, et al. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction. Br J Dermatol. 2005;152:1304-1312.
-
(2005)
Br J Dermatol
, vol.152
, pp. 1304-1312
-
-
Papp, K.A.1
Tyring, S.2
Lahfa, M.3
|